The study will be 28 weeks in duration.
The study will be 28 weeks in duration.
The purpose of this study is to evaluate the study drug for efficacy (how well the drug works), safety (the side effects), and tolerability (how bearable) in children (7-11 years of age) and adolescents (12-17 years of age) with depression.
Participants must be between 7 and 17 years of age and have been depressed for at least 6 weeks.
Yes
PI: Steven Dubovsky, MD
Name: Sevie Kandefer, MS
Phone: (716) 898-4038
Email: sk293@buffalo.edu